RTP medtech firm Merakris launches new skin-graft alternative

The company describes the product, Dermacyte Matrix, as “a crosslinked amniotic membrane allograft designed for cutaneous wound applications, commonly used by outpatient surgical, podiatry and dermatology clinics.”

Read More